November 28, 2014 6:45 AM ET

Biotechnology

Company Overview of Syndax Pharmaceuticals, Inc.

Key Executives for Syndax Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Arlene M. Morris 129 RelationshipsChief Executive Officer, President and Director62
Michael Downes Ph.D.No RelationshipsCo-Founder--
Ronald M. Evans Ph.D.37 RelationshipsCo-Founder and Advisor--
Richard A. Heyman Ph.D.69 RelationshipsCo-Founder57
Peter Ordentlich Ph.D.No RelationshipsCo-Founder and Chief Technology Officer45
View More Key Executives

Syndax Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis G. Podlesak MBA 49 RelationshipsCalixa Therapeutics, Inc.56
Arlene M. Morris 129 RelationshipsSyndax Pharmaceuticals, Inc.62
Kim Puloma Kamdar Ph.D. 85 RelationshipsDomain Associates, L.L.C.46
Luke B. Evnin Ph.D. 106 RelationshipsMPM Capital51
Richard P. Shea 7 RelationshipsMomenta Pharmaceuticals Inc.62
View All Board Members

Syndax Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Richard P. Shea7 Relationships3 Executives
Compensation Committee Ph.D.Luke B. Evnin106 Relationships3 Executives
Nominating Committee Ph.D.Kim Puloma Kamdar85 Relationships3 Executives
Corporate Governance Committee Ph.D.Kim Puloma Kamdar85 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$409.5K
409.5K
362.2K
Bonus$178.0K
178.0K
206.7K
Total Short Term Compensation
Not meaningful
Total Value of Options$587.5K
587.5K
21.4M
Compensation as of Fiscal Year 2013
Syndax Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Harbinger Group Inc. Announces Management Changes
November 25, 2014 2:30 PM ET
Kimberly-Clark Corporation Announces Resignation of Robert E. Abernathy as President, Global Health
November 05, 2014 1:01 PM ET
Armored AutoGroup, Inc. Announces Management Changes
November 03, 2014 3:13 PM ET
Church & Dwight Co. Inc. Appoints Matthew T. Farrell as Chief Operating Officer and Chief Financial Officer
November 03, 2014 12:00 PM ET
Vinda International Holdings Limited Appoints WONG Kwai Huen, Albert, as a Member of the Audit Committee and Nomination Committee
November 03, 2014 5:37 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.